CEO buys shares in Stayble Therapeutics
Stayble Therapeutics AB (”Stayble” or the ”Company”) announces today that the Company’s CEO Andreas Gerward has purchased 15,000 shares in the Company for a total value of 73 350 SEK. The shares have been purchased in the open market.Andreas Gerward purchased shares on 31 August 2022 and acquired a total of 15,000 shares at a price of 4.89 SEK per share. After the transaction, Andreas owns 360 000 stocks in the Company.